Albemarle Corporation (NYSE:ALB – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirty analysts that are covering the company, MarketBeat reports. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating, thirteen have issued a buy rating and four have assigned a strong buy rating to the company. The average twelve-month price objective among brokers that have covered the stock in the last year is $161.16.
A number of research firms have issued reports on ALB. Citigroup raised their price target on shares of Albemarle from $150.00 to $180.00 and gave the stock a “neutral” rating in a report on Wednesday, January 21st. UBS Group upped their target price on Albemarle from $185.00 to $205.00 and gave the company a “buy” rating in a research report on Monday, January 12th. Rothschild & Co Redburn lifted their price target on Albemarle from $135.00 to $158.00 and gave the stock a “buy” rating in a research report on Thursday, December 4th. Robert W. Baird set a $210.00 price target on Albemarle and gave the company an “outperform” rating in a research note on Wednesday, January 7th. Finally, Evercore ISI raised their price objective on Albemarle from $88.00 to $100.00 and gave the stock an “in-line” rating in a research note on Tuesday, November 11th.
View Our Latest Analysis on Albemarle
Institutional Trading of Albemarle
Albemarle Trading Down 5.1%
Albemarle stock opened at $184.27 on Thursday. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.51 and a current ratio of 2.27. The stock has a market cap of $21.69 billion, a PE ratio of -115.89, a price-to-earnings-growth ratio of 4.48 and a beta of 1.41. The stock has a 50-day moving average of $147.69 and a two-hundred day moving average of $107.71. Albemarle has a one year low of $49.43 and a one year high of $195.68.
Albemarle (NYSE:ALB – Get Free Report) last posted its quarterly earnings data on Wednesday, November 5th. The specialty chemicals company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.92) by $0.73. The firm had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.27 billion. Albemarle had a negative net margin of 0.43% and a positive return on equity of 0.10%. The company’s revenue for the quarter was down 3.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($1.55) earnings per share. On average, research analysts anticipate that Albemarle will post -0.04 EPS for the current fiscal year.
About Albemarle
Albemarle Corporation is a leading global specialty chemicals company primarily engaged in the production and distribution of lithium, bromine, and catalysts. Its lithium segment supplies key components used in rechargeable batteries for electric vehicles, portable electronics, and grid storage systems. The company’s bromine specialty products serve a wide range of industries, including oil and gas drilling fluids, fire safety solutions, and water treatment. In its catalysts division, Albemarle provides products for petroleum refining, chemical processing and emissions control.
Founded in 1994 as a spin-off from Ethyl Corporation, Albemarle has grown through strategic acquisitions and capacity expansions to become one of the world’s foremost chemical producers.
Featured Stories
- Five stocks we like better than Albemarle
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
- A U.S. “birthright” claim worth trillions – activated quietly
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.
